{
    "organizations": [],
    "uuid": "ed15dc76831172b48334e78a423bbc2b16327648",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-enterprise-therapeutics-says-raise/brief-enterprise-therapeutics-says-raised-29-mln-in-series-b-round-idUSFWN1RP0L9",
    "ord_in_thread": 0,
    "title": "BRIEF-Enterprise Therapeutics Says Raised £29 Mln In Series B Round",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - Enterprise Therapeutics:\n* ENTERPRISE THERAPEUTICS SAYS RAISED £29 MLN ($41 MLN) IN SERIES B ROUND CO-LED BY VERSANT VENTURES AND NOVARTIS VENTURE FUND Source text for Eikon:\n ",
    "published": "2018-04-12T20:49:00.000+03:00",
    "crawled": "2018-04-13T17:31:23.023+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "enterprise",
        "therapeutic",
        "enterprise",
        "therapeutic",
        "say",
        "raised",
        "mln",
        "mln",
        "series",
        "b",
        "round",
        "versant",
        "venture",
        "novartis",
        "venture",
        "fund",
        "source",
        "text",
        "eikon"
    ]
}